1. Home
  2. SGHT vs BLFY Comparison

SGHT vs BLFY Comparison

Compare SGHT & BLFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • BLFY
  • Stock Information
  • Founded
  • SGHT 2011
  • BLFY 1939
  • Country
  • SGHT United States
  • BLFY United States
  • Employees
  • SGHT N/A
  • BLFY N/A
  • Industry
  • SGHT Medical Specialities
  • BLFY Commercial Banks
  • Sector
  • SGHT Health Care
  • BLFY Finance
  • Exchange
  • SGHT Nasdaq
  • BLFY Nasdaq
  • Market Cap
  • SGHT 179.7M
  • BLFY 196.6M
  • IPO Year
  • SGHT 2021
  • BLFY N/A
  • Fundamental
  • Price
  • SGHT $4.12
  • BLFY $8.65
  • Analyst Decision
  • SGHT Buy
  • BLFY Hold
  • Analyst Count
  • SGHT 8
  • BLFY 1
  • Target Price
  • SGHT $4.16
  • BLFY $10.00
  • AVG Volume (30 Days)
  • SGHT 120.0K
  • BLFY 58.3K
  • Earning Date
  • SGHT 08-07-2025
  • BLFY 07-30-2025
  • Dividend Yield
  • SGHT N/A
  • BLFY N/A
  • EPS Growth
  • SGHT N/A
  • BLFY N/A
  • EPS
  • SGHT N/A
  • BLFY N/A
  • Revenue
  • SGHT $76,303,000.00
  • BLFY $41,939,000.00
  • Revenue This Year
  • SGHT N/A
  • BLFY $20.14
  • Revenue Next Year
  • SGHT $11.22
  • BLFY $20.20
  • P/E Ratio
  • SGHT N/A
  • BLFY N/A
  • Revenue Growth
  • SGHT N/A
  • BLFY 0.22
  • 52 Week Low
  • SGHT $2.03
  • BLFY $8.24
  • 52 Week High
  • SGHT $7.05
  • BLFY $11.38
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 60.97
  • BLFY 40.06
  • Support Level
  • SGHT $3.11
  • BLFY $8.45
  • Resistance Level
  • SGHT $4.27
  • BLFY $8.83
  • Average True Range (ATR)
  • SGHT 0.23
  • BLFY 0.26
  • MACD
  • SGHT 0.09
  • BLFY -0.02
  • Stochastic Oscillator
  • SGHT 87.07
  • BLFY 40.49

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

Share on Social Networks: